Albion Financial Group UT Cuts Stock Holdings in The Clorox Company (NYSE:CLX)

Albion Financial Group UT lessened its stake in The Clorox Company (NYSE:CLX) by 0.9% during the fourth quarter, Holdings Channel reports. The firm owned 32,105 shares of the company’s stock after selling 284 shares during the period. Albion Financial Group UT’s holdings in Clorox were worth $5,214,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in CLX. Catalyst Capital Advisors LLC acquired a new position in Clorox in the third quarter valued at $54,000. AQR Capital Management LLC lifted its stake in shares of Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company’s stock valued at $39,121,000 after purchasing an additional 22,676 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Clorox by 5.6% during the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company’s stock worth $31,266,000 after purchasing an additional 10,149 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp increased its position in Clorox by 60.5% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 23,769 shares of the company’s stock worth $3,244,000 after purchasing an additional 8,957 shares in the last quarter. Finally, Advisors Asset Management Inc. raised its holdings in Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company’s stock valued at $4,865,000 after buying an additional 9,037 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 0.2 %

CLX stock opened at $160.03 on Wednesday. The company has a market capitalization of $19.81 billion, a P/E ratio of 55.76, a PEG ratio of 2.95 and a beta of 0.42. The firm has a 50 day simple moving average of $164.16 and a 200-day simple moving average of $156.91. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the business earned $0.49 EPS. The firm’s revenue for the quarter was up 27.0% compared to the same quarter last year. On average, equities research analysts predict that The Clorox Company will post 6.87 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.05%. Clorox’s payout ratio is 170.04%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the stock. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and increased their price target for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Evercore ISI reduced their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Four investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $156.54.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.